Does Retrovir Interact with Atidarsagene Autotemcel?
CDI records a major classification for Retrovir and Atidarsagene Autotemcel. The stored summary is: Do not take anti-retroviral medications for at least one month prior to initiating stem cell mobilization. Anti-retroviral medications may interfere with the manufacturing of LENMELDY. The mechanism involves interference with manufacturing process. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Interference with manufacturing process
What To Tell Your Doctor or Pharmacist
If you are taking Retrovir and your doctor is considering prescribing Atidarsagene Autotemcel (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider